Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Bupivacaine measurement |
Component |
True |
Bupivacaine (substance) |
Inferred relationship |
Some |
1 |
Bupivacaine hydrochloride |
Is a |
False |
Bupivacaine (substance) |
Inferred relationship |
Some |
|
Product containing bupivacaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bupivacaine (substance) |
Inferred relationship |
Some |
1 |
Bupivacaine poisoning |
Causative agent |
True |
Bupivacaine (substance) |
Inferred relationship |
Some |
1 |
Accidental bupivacaine poisoning |
Causative agent |
False |
Bupivacaine (substance) |
Inferred relationship |
Some |
|
Intentional bupivacaine poisoning |
Causative agent |
False |
Bupivacaine (substance) |
Inferred relationship |
Some |
|
forgiftning med bupivacain, uvist med hvilken hensigt |
Causative agent |
False |
Bupivacaine (substance) |
Inferred relationship |
Some |
1 |
Bupivacaine adverse reaction |
Causative agent |
True |
Bupivacaine (substance) |
Inferred relationship |
Some |
1 |
Allergy to bupivacaine (finding) |
Causative agent |
False |
Bupivacaine (substance) |
Inferred relationship |
Some |
|
Bupivacaine overdose |
Causative agent |
True |
Bupivacaine (substance) |
Inferred relationship |
Some |
1 |
Accidental bupivacaine overdose |
Causative agent |
True |
Bupivacaine (substance) |
Inferred relationship |
Some |
1 |
Intentional bupivacaine overdose (disorder) |
Causative agent |
True |
Bupivacaine (substance) |
Inferred relationship |
Some |
1 |
overdosis af bupivacain, uvist med hvilken hensigt |
Causative agent |
False |
Bupivacaine (substance) |
Inferred relationship |
Some |
1 |
bupivacain 3,75 mg/ml (0,375 %) injektionsvæske, opløsning, steril ampul a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine (substance) |
Inferred relationship |
Some |
|
bupivacain 0,5 % + glucose injektionsvæske, opløsning, ampul a 4 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine (substance) |
Inferred relationship |
Some |
|
bupivacain 0,105 % infusionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine (substance) |
Inferred relationship |
Some |
|
Product containing bupivacaine and epinephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bupivacaine (substance) |
Inferred relationship |
Some |
1 |
bupivacain + glucose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine (substance) |
Inferred relationship |
Some |
1 |
bupivacain 2,5 mg/ml (0,25 %) injektionsvæske, opløsning, ampul a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine (substance) |
Inferred relationship |
Some |
|
bupivacain 2,5 mg/ml (0,25 %) injektionsvæske, opløsning, steril ampul a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine (substance) |
Inferred relationship |
Some |
|
bupivacain 5 mg/ml (0,5 %) injektionsvæske, opløsning, ampul a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine (substance) |
Inferred relationship |
Some |
|
bupivacain 5 mg/ml (0,5 %) injektionsvæske, opløsning, steril ampul a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine (substance) |
Inferred relationship |
Some |
|
bupivacain 7,5 mg/ml (0,75 %) injektionsvæske, opløsning, plastikampul a 10ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine (substance) |
Inferred relationship |
Some |
|
bupivacain + adrenalin 0,25 %/1:200.000 sterilt indpakket injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine (substance) |
Inferred relationship |
Some |
|
bupivacain + adrenalin 0,5 %/1:200.000 sterilt indpakket injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine (substance) |
Inferred relationship |
Some |
|
bupivacainhydrochlorid + adrenalin 0,75 %/1:200.000 injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine (substance) |
Inferred relationship |
Some |
|
bupivacainhydrochlorid 5 mg + adrenalin 5 µg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine (substance) |
Inferred relationship |
Some |
|
bupivacainhydrochlorid 7,5 mg + adrenalin 0,005 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine (substance) |
Inferred relationship |
Some |
|
bupivacainhydrochlorid 2,5 mg + adrenalinbitartrat 5 µg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine (substance) |
Inferred relationship |
Some |
|
bupivacainhydrochlorid 5 mg + adrenalinbitartrat 0,0091 mg injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine (substance) |
Inferred relationship |
Some |
|
bupivacainhydrochlorid 2,5 mg + methylparaben 1 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine (substance) |
Inferred relationship |
Some |
|
bupivacainhydrochlorid 7,5 mg/glucose 82,5 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine (substance) |
Inferred relationship |
Some |
|
Levobupivacaine (substance) |
Is a |
False |
Bupivacaine (substance) |
Inferred relationship |
Some |
|
bupivacainhydrochlorid + adrenalin 0,5 %/50 µg/10 ml (1:200.000) injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine (substance) |
Inferred relationship |
Some |
|
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine (substance) |
Inferred relationship |
Some |
|
bupivacainhydrochlorid + fentanyl |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine (substance) |
Inferred relationship |
Some |
|
bupivacainhydrochlorid + fentanyl 0,1%/2µg/mL injektion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine (substance) |
Inferred relationship |
Some |
|
Product containing bupivacaine and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bupivacaine (substance) |
Inferred relationship |
Some |
1 |
lidocain 1 %/bupivacain 0,375 % injektionsvæske, opløsning, 10 ml hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine (substance) |
Inferred relationship |
Some |
|
Bupivacaine + dextrose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine (substance) |
Inferred relationship |
Some |
|
Accidental bupivacaine poisoning |
Causative agent |
True |
Bupivacaine (substance) |
Inferred relationship |
Some |
1 |
Intentional bupivacaine poisoning |
Causative agent |
True |
Bupivacaine (substance) |
Inferred relationship |
Some |
1 |
Cystoscopic injection of bupivacaine into ureter |
Direct substance |
False |
Bupivacaine (substance) |
Inferred relationship |
Some |
1 |
Cystoscopic injection of bupivacaine into ureter |
Direct substance |
True |
Bupivacaine (substance) |
Inferred relationship |
Some |
1 |
Allergy to bupivacaine (finding) |
Causative agent |
True |
Bupivacaine (substance) |
Inferred relationship |
Some |
1 |
Product containing bupivacaine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bupivacaine (substance) |
Inferred relationship |
Some |
1 |
Bupivacaine hydrochloride |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Bupivacaine (substance) |
Inferred relationship |
Some |
|
Bupivacaine 3.75mg/mL(0.375%) injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine (substance) |
Inferred relationship |
Some |
|
Bupivacaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bupivacaine (substance) |
Inferred relationship |
Some |
1 |
Product containing only bupivacaine and epinephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bupivacaine (substance) |
Inferred relationship |
Some |
1 |
Product containing only bupivacaine and glucose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine (substance) |
Inferred relationship |
Some |
1 |
Bupivacaine and lidocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bupivacaine (substance) |
Inferred relationship |
Some |
1 |
Bupivacaine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bupivacaine (substance) |
Inferred relationship |
Some |
1 |
Adrenaline and bupivacaine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bupivacaine (substance) |
Inferred relationship |
Some |
1 |
Adrenaline- and bupivacaine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bupivacaine (substance) |
Inferred relationship |
Some |
1 |